MSCI’s broadest index of Asia-Pacific shares outside Japan dropped 1.08%, Australian stocks fell 0.56%,… The post Asian shares fall as Covid resurgence hits oil demand first...
European countries prepared on April 21 to resume deliveries of Johnson & Johnson’s Covid-19 vaccine and speed up the rollout after Europe’s drug regulator backed the...
This week, President Biden will convene 40 world leaders for a major climate conference. The event marks America’s return to the world stage on climate action...
The benefits of Johnson & Johnson’s COVID-19 vaccine outweigh a tiny risk of unusual blood clots forming, Europe’s The post EU safety regulators clear J&J COVID...
Still Believe Digital Vaccine Passports Are Something Made Up By Conspiracy Theorists? Authored by Robert Wheeler via The Organic Prepper blog, In my past articles I...
Not-So-Super League: All 6 English Teams Abandon Breakaway Soccer Group Update (1815ET): All six English clubs have now pulled out of the European Super League. Manchester...
European Drug Regulator Slaps Safety Warning On J&J Jab Due To Blood-Clot Links While Europe grapples with its own vaccine safety scandal, the EMA, the same...
The new week kicked off on a negative note, as all 3 major indexes pulled back from record highs. After applauding recent strong economic data, the...
Johnson & Johnson is slated to report first-quarter 2021 earnings on April 20 before the market opens. Over the past six months, shares of the medical...
BioElectronics Corp. (OTCPINK: BIEL) is heating up again in recent trading and looking to break out northbound again. Microcapdaily has been reporting on BIEL for years and covered them...
A stunning first quarter in venture capital funding was not restricted to the United States; Europe also had one hell of a start to the year.
The antiparasitic drug was thought to be a potential treatment for COVID-19, but there isn't sufficient evidence to recommend its use, despite widespread support online.
The antiparasitic drug was thought to be a potential treatment for COVID-19, but there isn't sufficient evidence to recommend its use, despite widespread support online.
Key Events In The Coming Week: All About Earnings And The ECB As Jim Reid summarizes events over the next five days, there’s a reasonably eventful...
Key Events In The Coming Week: All About Earnings And The ECB As Jim Reid summarizes events over the next five days, there’s a reasonably eventful...
The EU has continued a refocus of its COVID-19 vaccination drive on mRNA shots, ordering another 100 million doses,
The Canadian dollar had a quiet week, as the currency continues to trade close to the 1.25 level. In the European session, USD/CAD is trading at...
The Canadian dollar had a quiet week, as the currency continues to trade close to the 1.25 level. In the European session, USD/CAD is trading at...
Stock markets all over the world smashed records as the Covid rebound picked up speed....will it last?
The latest Techstars Seattle cohort kicked off an entirely virtual 3-month startup accelerator journey in January. Unlike the 2020 class, which had to pivot to a...
The State Of The 'Third Wave' In Europe While the growth of COVID-19 infections is slowing down in some European countries, others are experiencing an increase in case...
Globalists Will Need Another Crisis In America As Their Reset Agenda Fails Authored by Brandon Smith via Alt-Market.us, It might sound like “US exceptionalism” to point...
Globalists Will Need Another Crisis In America As Their Reset Agenda Fails Authored by Brandon Smith via Alt-Market.us, It might sound like “US exceptionalism” to point...
Mercedes-Benz lifted the final veil Thursday on its flagship EQS sedan after weeks of teasers, announcements and even a pre-production drive in which TechCrunch participated. The...
The Defender's modifications were partially designed by the duke himself.
As a society, we have to choose between liberty, equality and mortality. We can't have all three.
As a society, we have to choose between. We can't have all three.
European equities head higher European bourses are on the rise rounding off an upbeat week. Following all-time highs on Wall Street overnight and record Chinese quarterly...
Activist investor Elliott Management has built a significant stake in GlaxoSmithKline, after a poor run of clinical trial The post Activist investor Elliott builds stake in...
A study has suggested that the risk of getting a serious brain clot is eight to 10 times The post Risk of brain clots higher with...